CLINICAL TRIALS PROFILE FOR FIRVANQ KIT

All Clinical Trials for FIRVANQ KIT

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT06148025 ↗	Antibiotics and Vaccine Immune Responses Study	Recruiting	Centenary Institute of Cancer Medicine and Cell Biology	Phase 4	2023-11-23	The goal of this clinical trial is to examine immune responses to the BCG vaccine in healthy adults who have, or who have not, taken antibiotics to deplete their gut bacteria prior to vaccination. The main question it aims to answer is: does depletion of the gut microbiota lead to impaired BCG-induced protection against specific and non-specific to challenges to the immune system?
NCT06148025 ↗	Antibiotics and Vaccine Immune Responses Study	Recruiting	Flinders University	Phase 4	2023-11-23	The goal of this clinical trial is to examine immune responses to the BCG vaccine in healthy adults who have, or who have not, taken antibiotics to deplete their gut bacteria prior to vaccination. The main question it aims to answer is: does depletion of the gut microbiota lead to impaired BCG-induced protection against specific and non-specific to challenges to the immune system?
NCT06148025 ↗	Antibiotics and Vaccine Immune Responses Study	Recruiting	Royal Adelaide Hospital	Phase 4	2023-11-23	The goal of this clinical trial is to examine immune responses to the BCG vaccine in healthy adults who have, or who have not, taken antibiotics to deplete their gut bacteria prior to vaccination. The main question it aims to answer is: does depletion of the gut microbiota lead to impaired BCG-induced protection against specific and non-specific to challenges to the immune system?
NCT06148025 ↗	Antibiotics and Vaccine Immune Responses Study	Recruiting	Telethon Kids Institute	Phase 4	2023-11-23	The goal of this clinical trial is to examine immune responses to the BCG vaccine in healthy adults who have, or who have not, taken antibiotics to deplete their gut bacteria prior to vaccination. The main question it aims to answer is: does depletion of the gut microbiota lead to impaired BCG-induced protection against specific and non-specific to challenges to the immune system?
NCT06148025 ↗	Antibiotics and Vaccine Immune Responses Study	Recruiting	University of Sydney	Phase 4	2023-11-23	The goal of this clinical trial is to examine immune responses to the BCG vaccine in healthy adults who have, or who have not, taken antibiotics to deplete their gut bacteria prior to vaccination. The main question it aims to answer is: does depletion of the gut microbiota lead to impaired BCG-induced protection against specific and non-specific to challenges to the immune system?

Clinical Trial Conditions for FIRVANQ KIT

Condition Name

Condition Name for FIRVANQ KIT
Intervention	Trials
Vaccine Response Impaired	1

Condition MeSH

Condition MeSH for FIRVANQ KIT
Intervention	Trials

Clinical Trial Locations for FIRVANQ KIT

Trials by Country

Trials by Country for FIRVANQ KIT
Location	Trials
Australia	1

Clinical Trial Progress for FIRVANQ KIT

Clinical Trial Phase

Clinical Trial Phase for FIRVANQ KIT
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for FIRVANQ KIT
Clinical Trial Phase	Trials
Recruiting	1

Clinical Trial Sponsors for FIRVANQ KIT

Sponsor Name

Sponsor Name for FIRVANQ KIT
Sponsor	Trials
Centenary Institute of Cancer Medicine and Cell Biology	1
Flinders University	1
Royal Adelaide Hospital	1

Sponsor Type

Sponsor Type for FIRVANQ KIT
Sponsor	Trials
Other	6